Form 4 for OPRX OptimizeRx Corp
Accepted 2024-05-06 00:00:00 ET · period of report 2024-05-02 · accession 0001628280-24-020821 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-05-06 | 2024-05-02 | OPRX | Silvestro Stephen L | Chief Commercial Off | F - Tax | $10.70 | -35.4K | 72.8K | -33% | -$378.9K |
| D | 2024-05-06 | 2024-05-02 | OPRX | Silvestro Stephen L | Chief Commercial Off | M - OptEx | $0.00 | +90.0K | 108.3K | +493% | $0 |
| D | 2024-05-06 | 2024-05-02 | OPRX | Silvestro Stephen L | Chief Commercial Off | M - OptEx | $0.00 | -90.0K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-05-02 | F | D | 35,415 | $10.70 | 72,846 | D | — | — | (F2) These shares were withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations. Such withholding is treated as a disposition of securities under Section 16 of the Securities Exchange Act of 1934, as amended. |
| 2 | Common | Common Stock | 2024-05-02 | M | A | 90,000 | $0.00 | 108,261 | D | — | — | (F1) Each restricted stock unit represents a contingent right to receive one share of OptimizeRx common stock. |
| 3 | Derivative | Restricted Stock Units | 2024-05-02 | M | D | 90,000 | $0.00 | 0 | D | — · 2024-05-02 to 2024-05-02 | 90,000 Common Stock | (F1) Each restricted stock unit represents a contingent right to receive one share of OptimizeRx common stock. (F3) The restricted stock units cliff vested in full on May 2, 2024, the fifth anniversary of the grant date. |